IL 3625 (Theophylline extended-release 300 mg)

Pill imprint IL 3625 has been identified as Theophylline extended-release 300 mg.

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for IL 3625

Theophylline extended-release 300 mg IL 3625 Front
Theophylline extended-release 300 mg IL 3625 Back
Theophylline extended-release 300 mg IL 3625
Theophylline extended-release
Imprint:
IL
3625
Strength:
300 mg
Color:
White / Clear
Size:
17.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Inwood Laboratories Inc.
National Drug Code (NDC):
00258-3625
Inactive Ingredients:
ferric oxide black
butylparaben
castor oil
edetate calcium disodium
ethylcellulose
gelatin
methylparaben
pharmaceutical glaze
povidone
propylparaben
sodium lauryl sulfate
sodium propionate
starch
sugar spheres
magnesium silicate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)